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Abstract  18 
Analysis of temperature-sensitive (ts) mutant viruses is a classic method allowing 19 
researchers to identify genetic loci involved in viral replication and pathogenesis. Here, 20 
we report genetic analysis of a ts strain of mouse hepatitis virus (MHV), tsNC11, 21 
focusing on the role of mutations in the macrodomain and the papain-like protease 2 22 
(PLP2) domain of nonstructural protein 3, a component of the viral replication complex. 23 
Using MHV reverse genetics, we generated a series of mutant viruses to define the 24 
contribution of macrodomain- and PLP2-specific mutations to the ts phenotype. Viral 25 
replication kinetics and efficiency of plating analysis performed at permissive and non-26 
permissive temperatures revealed that changes in the macrodomain alone were both 27 
necessary and sufficient for the ts phenotype. Interestingly, mutations in the PLP2 28 
domain were not responsible for the temperature sensitivity but did reduce the 29 
frequency of reversion of macrodomain mutants. Co-immunoprecipitation studies are 30 
consistent with an interaction between the macrodomain and PLP2. Expression studies 31 
of the macrodomain-PLP2 portion of nsp3 indicate that the ts mutations enhance the 32 
proteasome-mediated degradation of the protein. Furthermore, we found that during 33 
virus infection, the replicase proteins containing the MAC and PLP2 mutations were 34 
more rapidly degraded at the non-permissive temperature, as compared to the wild-type 35 
proteins. Importantly, we show that the macrodomain- and PLP2-mutant viruses trigger 36 
production of type I interferon in vitro and are attenuated in mice, further highlighting the 37 














Coronaviruses are emerging human and veterinary pathogens with pandemic potential. 42 
Despite the established and predicted threat these viruses pose to human health, there 43 
are currently no approved countermeasures to control these infections in humans. Viral 44 
macrodomains, enzymes that remove post-translational ADP-ribosylation of proteins, 45 
and viral multifunctional papain-like proteases, enzymes that cleave polyproteins and 46 
remove polyubiquitin chains via deubiquitinating (DUB) activity, are two important 47 
virulence factors. Here, we reveal an unanticipated interplay between the macrodomain 48 
and the PLP2 domain that is important for replication and antagonizing the host innate 49 
immune response. Targeting the interaction of these enzymes may provide new 50 
therapeutic opportunities to treat CoV disease.  51 
 52 
Introduction 53 
 Coronaviruses (CoVs) are enveloped, positive-sense, single-stranded RNA 54 
viruses that primarily infect the respiratory or gastrointestinal tract. CoVs can emerge 55 
from an animal reservoir, such as bats, to infect a new species and cause epidemic or 56 
pandemic disease with high mortality. Recent emergence events exemplified by Severe 57 
Acute Respiratory Syndrome coronavirus (SARS-CoV) and Middle East Respiratory 58 
Syndrome coronavirus (MERS-CoV) in humans (1), and Swine Acute Diarrhea 59 
Syndrome coronavirus (SADS-CoV) in domestic pigs (2), have demonstrated how 60 
devastating these viruses can be within naïve populations. To date, there are no 61 
approved antivirals or effective vaccines that protect humans from coronavirus 62 
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diseases. Therefore, identifying viral factors that contribute to pathogenesis and 63 
characterizing novel targets for therapeutic interventions are two important approaches 64 
to facilitate the development of effect vaccines and antivirals. 65 
 The murine coronavirus, mouse hepatitis virus (MHV), is widely used as a model 66 
system to study coronavirus replication and pathogenesis in mice. The replication of the 67 
virus initiates with the engagement of the spike glycoprotein with a host cell receptor 68 
and the release of the positive-sense RNA into the cytoplasm of the cell. The large (~32 69 
Kb) viral genomic RNA is translated to produce two long polyproteins, pp1a and pp1ab, 70 
which are processed by viral proteases, including the papain-like proteases (PLP1 71 
and/or PLP2), and the 3C-like protease (3CLpro or Mpro), into 16 nonstructural proteins 72 
(nsp1-16, Figure 1A). To generate the viral replication complex, the coronaviral nsps 73 
sequester host endoplasmic reticulum (ER) to generate convoluted membranes and 74 
double-membrane vesicles (DMVs), which are the sites of viral RNA synthesis (3, 4). 75 
The viral replication complex generates a nested-set of dsRNA intermediates to 76 
produce copious amounts of mRNAs, which are then translated to produce the 77 
structural (spike, envelope, membrane and nucleocapsid) and virus-specific accessory 78 
proteins. The genomic RNA and structural proteins assemble in the ER-Golgi 79 
intermediate compartment to generate infectious virus particles that are released from 80 
the cell (5, 6).  81 
CoV replication induces profound rearrangement of the host ER, and generates 82 
viral dsRNA intermediates, processes that can be sensed by the host to activate the 83 
innate immune response. As a result, CoVs have evolved multiple strategies to 84 
counteract and delay activation of these host immune responses and establish an 85 
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environment amenable to virus replication. These strategies include: expressing 86 
species-specific accessory proteins as modulators of innate immune responses 87 
[reviewed in (7)]; encoding highly-conserved nonstructural proteins that serve as 88 
interferon antagonists (8–10) and sequestering viral RNA in DMVs (3, 4) to prevent 89 
detection by host pattern recognition receptors.  A key component in the assembly of 90 
the DMVs is nsp3 (11, 12). To date, eleven distinct nsp3 domains have been identified 91 
using either bioinformatic approaches or enzymatic studies (Figure 1A). Here, we focus 92 
on two multifunctional components encoded within nsp3, the macrodomain and the 93 
papain-like protease 2. 94 
The region researchers now term the macrodomain was originally identified in 95 
the 1990s as a highly-conserved domain of unknown function, termed the X domain, 96 
contained within the replicase polyprotein of rubella virus, hepatitis E virus (HEV) and 97 
coronaviruses (13–15). Structural and biochemical studies revealed that the X domain 98 
exhibited structural similarity to the cellular histone MacroH2a and catalyzed 99 
measurable ADP-ribose-1’’-phosphatase (ADRP) activity (16–18), although the 100 
functional significance of this enzymatic activity was unclear. Using reverse genetics to 101 
inactivate the catalytic site of the enzyme, researchers found that ADRP activity was not 102 
essential for CoV replication in cultured cells (19). However, further studies revealed 103 
that an ADRP-catalytic mutant virus was attenuated in mice (20), and that ADRP activity 104 
in SARS-CoV and human CoV-229E mediated resistance to antiviral interferon 105 
responses (21). These findings were consistent with an essential role for enzymatic 106 
activity in vivo; although, the target for the ADRP activity was still unclear. A 107 
breakthrough came in 2016 from a study revealing that the macrodomain of hepatitis E 108 
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virus acts as an ADP-ribose hydrolase (22). ADP-ribosylation is a known post-109 
translational modification that regulates cellular activities (23); therefore, viral enzymes 110 
that reverse this process could interrupt host-cell signaling. For CoVs, nsp3 111 
macrodomain activity was shown to promote MHV-induced encephalitis (24) and 112 
increase virulence during SARS-CoV infection (25).  113 
Another highly-conserved enzyme contained within nsp3 is the papain-like 114 
protease 2 (PLP2). For MHV, PLP2 is responsible for processing the nsp3/4 junction 115 
using a highly-conserved LXGG/X cleavage site (26). Studies using SARS-CoV 116 
revealed that the single papain-like protease encoded on nsp3 (termed PLpro) cleaves 117 
all three sites at the amino-terminal end of the polyprotein (27). PLpro also functions as 118 
a deubiquitinating enzyme (DUB), capable of removing polyubiquitin chains from 119 
substrates (28, 29). Structural studies revealed that CoV PLpro/PLP2s are similar to 120 
cellular DUBs (30). Enzymatic analysis revealed that CoV PLpro/PLP2s are 121 
multifunctional with protease, deubiquitinating and deISGylating activity (30–33). The 122 
viral DUB activity has been implicated as a modulator of the innate immune response to 123 
viral infection (32, 34, 35), but the target(s) of the DUB activity have not yet been 124 
identified. Thus, both the PLP2 and macrodomains of nsp3 have been independently 125 
identified as contributors to coronavirus virulence. 126 
 In this study, we characterized a temperature-sensitive MHV mutant virus 127 
containing mutations within both the macrodomain and PLP2 domain. We investigated 128 
the contribution of these mutations to the temperature-sensitive phenotype as well as 129 
the resulting effects on viral pathogenesis. The results presented here reveal a 130 
previously undescribed interplay between the macrodomain and PLP2 domain that 131 
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impacts replication, antagonizes the innate immune response, and contributes to viral 132 
pathogenesis. Modulating the macrodomain-PLP2 interaction may provide new 133 
opportunities for therapeutic intervention. 134 
Results 135 
Identifying mutations associated with a temperature-sensitive phenotype. Murine 136 
coronavirus strain tsNC11 was generated by chemical mutagenesis, plaque purified, 137 
and validated as a temperature-sensitive (ts) mutant defective in positive-sense RNA 138 
synthesis at non-permissive temperatures (36). Complementation analysis indicated 139 
that tsNC11 harbored mutation(s) in the ORF1a region of the replicase polyprotein, but 140 
the specific mutations were unknown. To identify the nucleotide changes in tsNC11, we 141 
isolated the genomic RNA from viral supernatant, subjected it to deep sequencing then 142 
aligned the reads to the genomic sequence of MHV-A59 (GenBank accession 143 
#AY910861). In agreement with the complementation study by Schaad et al. (36), the 144 
sequence analysis revealed 7 non-synonymous substitutions in the ORF1a of tsNC11. 145 
These substitutions resulted in 7 amino acid changes: two in nsp2 (I4V and T543I), four 146 
in nsp3, and one in nsp10 (P23S). The four mutations within nsp3 are distributed 147 
between the macrodomain (K532E and G554D) and the PLP2 domain (D1026N and 148 
D1071N) (Figure 1A). As noted above, previous studies documented the importance of 149 
the macrodomain and PLP2 domain in virus replication and disease; therefore, we 150 
focused our efforts on evaluating how these substitutions contributed to the ts 151 
phenotype, the stability of the phenotype, and the pathogenesis of the virus in mice.  152 
To evaluate the contributions of the macrodomain and PLP2 domain mutations to 153 
the ts phenotype, three mutant viruses were generated using the MHV-A59 reverse 154 
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genetics system (37). The first mutant virus, designated MACmut, contains the 155 
macrodomain mutations K532E and G554D. The second virus was engineered with the 156 
D1026N and D1071N mutations within the PLP2 domain and is designated PLP2mut. 157 
The third virus, MAC/PLP2mut, combines the mutations in the macro- and PLP2 158 
domains into one virus. In addition, an isogenic wild-type MHV (icWT) was used as a 159 
control. These viruses were recovered, plaque purified, and propagated in DBT cells at 160 
a permissive temperature of 32oC. Deep-sequencing results confirmed the incorporation 161 
of the desired nucleotide changes in nsp3 and revealed no additional amino acid 162 
changes within the ORF1 region. 163 
First, we evaluated the one-step growth curves of all 5 viruses (tsNC11, icWT 164 
and the 3 engineered mutants) at the permissive (32oC) and non-permissive (37oC and 165 
40oC) temperatures. As expected, icWT replicates to high titer at all three temperatures, 166 
whereas tsNC11 is impaired at both 37oC and 40oC, as reported by Schaad et al. (36) 167 
(Fig. 1B). Analysis of the three engineered mutants revealed that the two substitutions 168 
in the PLP2 domain were not sufficient to confer a temperature-sensitive phenotype, as 169 
the kinetics of replication mirrored those of the wild-type virus. In contrast, the MACmut 170 
virus exhibited reduced virus replication at 40oC, but was only slightly impaired at 37oC. 171 
The MAC/PLP2 mutant virus mirrored the kinetics of tsNC11 with impaired replication at 172 
both 37oC and 40oC, implicating the mutations in both the macro- and PLP2 domains as 173 
contributors to the temperature-sensitive phenotype of tsNC11.  174 
We also evaluated the plaque size and efficiency of plating (EOP) of the viruses 175 
at permissive and non-permissive temperatures. As expected, all viruses replicated to 176 
high titer and formed similarly-sized plaques at 32oC (Figure 2, upper panel). tsNC11 is 177 
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profoundly temperature-sensitive, with a low number of plaques detected at the 10-1 178 
dilution plate incubated at the non-permissive temperature. The tsNC11 plaques that 179 
were detected at the non-permissive temperature exhibited a large-plaque phenotype 180 
suggesting that these viruses may be revertants. We found that the PLP2mut virus 181 
formed large plaques at 40oC, which is consistent with the results of the kinetic analysis 182 
and indicates that the mutations in the PLP2 domain are not sufficient to cause the ts 183 
phenotype. Analysis of the MACmut virus revealed a mixed population of small and 184 
large plaques at the non-permissive temperature, the majority of which displayed the 185 
small-plaque phenotype. The MAC/PLP2 mutant virus mirrored the plaque size and 186 
plating efficiency of tsNC11. We calculated the EOP values, which represent the ratio of 187 
viral titers obtained at 40oC and 32oC (Figure 2B). Again, both the PLP2mut and icWT 188 
viruses had similar titers at both temperatures, resulting in an EOP of ~1. In contrast, 189 
the MACmut virus exhibited titers that were significantly lower at 40oC compared to 190 
titers obtained at 32oC (EOP=10-2). These results indicate that the MACmut virus, but 191 
not the PLP2mut or icWT viruses, has a defect in plaque formation at the non-192 
permissive temperature. Taken together, these data demonstrate that the mutations in 193 
the macrodomain, but not those in the PLP2 domain, are the major determinants of the 194 
ts phenotype of tsNC11. Additionally, these results are consistent with a critical role of 195 
the macrodomain in viral replication. Interestingly, we found that the MAC/PLP2 mutant 196 
virus mirrored the plaque size and low reversion frequency of tsNC11 (EOP = 10-5), 197 
supporting a role for the PLP2 domain as a genetic enhancer of the ts phenotype. A 198 
genetic enhancer, as defined by genetic studies of eukaryotic organisms, is a mutation 199 
in one gene that intensifies the phenotype caused by a mutation in another gene (38). 200 
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Evaluating revertants of the MACmut virus. While generating the MACmut virus, we 201 
noticed that, in addition to the majority population having the small-plaque phenotype, a 202 
subpopulation of large plaques were also present at 40oC. The large plaques 203 
consistently appeared even after several rounds of plaque purification of the small-204 
plaque isolates. Therefore, we asked if the small plaques were formed by temperature-205 
sensitive viruses, while the large plaques were due to revertant viruses. To address this 206 
question, we selectively isolated plaques with different sizes and propagated them at 207 
32oC to obtain viral stocks for subsequent analysis (Figure 3). We found that the small-208 
plaque isolates recapitulated the phenotype of the parental MACmut virus: small 209 
plaques and similar EOP values (Figure 3A). In contrast, the large-plaque isolates 210 
exhibited a phenotype similar to icWT. Sequencing results of PCR amplicons, 211 
representing the region spanning the macro- and PLP2 domains, revealed that small-212 
plaque isolates had no additional mutations in either the macrodomain or PLP2. In 213 
contrast, the large-plaque isolates had either a true reversion (D554-to-G), or harbored 214 
putative suppressive mutations located within the macrodomain, or the adjacent, 215 
downstream sequence (Figure 3B). Among seven large-plaque revertants, all 216 
maintained the K532E mutation, indicating it was not associated with the ts phenotype. 217 
Three isolates had the D554-to-G reversion, suggesting that it may be sufficient for the 218 
ts phenotype of the MACmut virus. We found that isolates 4-7 maintained the 219 
engineered mutations, but had also acquired additional, potentially suppressive, 220 
mutations in the downstream region. Together, these results indicate that altering the 221 
coding sequence of either the macrodomain or the downstream region is likely sufficient 222 
to revert or suppress the ts phenotype caused by the G554D mutation.  We also 223 
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evaluated the MAC-PLP2 region of tsNC11 large-plaque revertant viruses and found 224 
that all three isolates had the D554-to-G reversion (Figure 3C), consistent with our 225 
findings with the MACmut revertants.  226 
Mutations in PLP2 enhance the ts phenotype by reducing reversion frequency.  227 
We determined that the macrodomain mutations are the major contributors to the ts 228 
phenotype; however, we noticed that the MACmut virus did not completely phenocopy 229 
tsNC11. We found that the replication of the MACmut virus was defective at 40oC, but 230 
not at 37oC. In addition, the MACmut virus exhibited a higher EOP value (10-2) 231 
compared to that of tsNC11 (10-4) (Fig 2B), indicating a relatively high reversion 232 
frequency. These data imply that mutations outside the macrodomain may enhance the 233 
ts phenotype by stabilizing the replication defect, thereby preventing reversion to the 234 
wild-type phenotype (38). Therefore, we asked if the addition of the PLP2 mutations 235 
observed in tsNC11 could enhance the ts phenotype of the MACmut virus and reduce 236 
reversion. We found that the MAC/PLP2mut virus exhibits a severe replication defect at 237 
both 37oC and 40oC (Figure 1B), and only replicated under permissive conditions, 238 
similar to tsNC11. The MAC/PLP2mut and tsNC11 viruses exhibited similar EOP values 239 
(~10-4) (Figure 2B). Of note, the low titer of the MAC/PLP2mut virus at 40oC indicates a 240 
low level of reversion to the wild-type phenotype, suggesting that the PLP2 mutations 241 
stabilize the MACmut virus. Taken together, these data demonstrate that while the 242 
PLP2 mutations are not sufficient to cause the ts phenotype, they act to enhance the ts 243 
phenotype caused by the mutation in the macrodomain. Enhancing phenotypes have 244 
been described for other coronavirus interacting proteins (39, 40), which motivated us to 245 
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determine if the enhancement phenotype we detected here is due to an interaction 246 
between the macro and PLP2 domains.  247 
Evaluating macrodomain interaction with the PLP2 domain. The structures of 248 
several domains of nsp3 have been solved individually [reviewed in (41)] or in 249 
combination (42). However, owing to the size and complexity this protein, the complete 250 
structure of nsp3 remains unsolved. The capacity of the PLP2 mutations to enhance the 251 
ts phenotype in the presence of the macrodomain mutations raises the possibility of 252 
domain-domain interaction between the macrodomain and PLP2. To test this 253 
hypothesis, we generated plasmids that express either an epitope-tagged macrodomain 254 
(HA-MAC) or PLP2 domain (PLP2-V5) (depicted in Figure 4A). When these plasmids 255 
were co-transfected into HEK-293T cells, the expression of both the macrodomain and 256 
PLP2 were detectable by the cognate epitope antibodies (Figure 4B). We detected HA-257 
MAC in lysates immunoprecipitated with anti-V5, and inversely, PLP2-V5 was detected 258 
when HA-MAC was immunoprecipitated from the lysates. These results indicate that the 259 
ectopically expressed macrodomain associates with PLP2 in cell lysates, consistent 260 
with either a direct or indirect interaction. 261 
Mutations in the macrodomain and PLP2 domain affect protein stability. Because 262 
we found that mutation in the macrodomain (G554D) is the major ts determinant and the 263 
PLP2 mutations enhance the ts phenotype, we reasoned that these mutations might 264 
alter protein folding, thereby rendering the protein unstable and susceptible to 265 
proteasome-mediated degradation. To determine if the mutations in the macrodomain 266 
and/or the PLP2 domain alter protein stability, plasmid DNA expressing wild-type or 267 
mutant forms of MAC/PLP2 polypeptide (Figure 5A) were transfected into HEK-293T 268 
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cells. The cells were maintained at 37oC throughout the experiment. We added 269 
cycloheximide (CHX) at 16 hours post-transfection to block translation, and harvested 270 
cell lysates at the indicated times.  The level of expressed proteins was determined by 271 
immunoblotting (Figure 5B and C). The MAC/PLP2 (WT) protein was maintained at 272 
levels comparable to those prior to treatment, up to 5 hours post-treatment with CHX. In 273 
contrast, we detected rapid reductions in the levels of all of the mutant forms of the 274 
protein. Addition of the proteasome inhibitor MG132 blocked the degradation of the 275 
proteins (Figures 5B and 5C). These results indicate that mutations in both the MAC 276 
and PLP2 domains affect the protein folding and stability, rendering the proteins more 277 
susceptible to proteasome-mediated degradation. 278 
     To determine if these MAC/PLP2 mutations affect the stability of the replicase 279 
proteins during virus replication at the non-permissive temperature, we performed 280 
temperature shift experiments as outlined in Figure 6. We infected cells with either WT 281 
or MAC/PLP2mut virus and incubated at the permissive temperature for 9.5 h.  At this 282 
point, we added CHX to block translation and shifted the infected-cells to the non-283 
permissive temperature. Cell lysates were collected every 30 minutes and evaluated 284 
using immunoblotting for the level of nonstructural intermediate nsp2-3 and product 285 
nsp3.  We found that WT nsp2-3 and nsp3 were relatively stable, with loss of detection 286 
occurring at 3 hours after the temperature shift and addition of CHX (Fig 6C, lanes 2-8).  287 
In contrast, the levels of nsp2-3 and nsp3 in the MAC/PLP2mut-infected cells 288 
diminished more rapidly, with reduced levels at 1.5 hours after the temperature shift and 289 
addition of CHX (Fig 6C, lanes 9-15). These results support the finding that the MAC 290 
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and PLP2 mutations destabilize the replicase protein at the non-permissive 291 
temperature. 292 
ts mutant viruses induce interferon in macrophages and are attenuated in mice. 293 
Previous studies have shown that the papain-like protease domains of MHV, SARS-294 
CoV, and MERS-CoV antagonize the IFN response, likely through the deubiquitinating 295 
activity of these enzymes (32, 34, 35, 43–46). In addition, coronaviral macrodomains 296 
have been shown to suppress IFN production both in vitro and in vivo (20, 21, 24, 25). 297 
We asked if the mutations in the macrodomain and PLP2 modulate the type I IFN 298 
response during infection of macrophages. As shown in Figure 7A, infection of mouse 299 
bone marrow-derived macrophages (BMDMs) with mutant viruses at permissive 300 
temperature produced significantly more IFN- during infection compared to the icWT 301 
virus infection. At 12 hours post-infection, the MACmut virus induced 2-fold more IFN- 302 
than icWT virus. Furthermore, the level of N gene transcript, which reveals the 303 
abundances of all viral mRNAs, was reduced in the MACmut-infected cells, compared 304 
to the wild type virus. We found that the PLP2mut virus elicited dramatically more IFN- 305 
than WT virus, while the level of N gene expression was similar. The MAC/PLP2mut 306 
virus exhibited the most robust IFN- and the lowest level of N gene expression. These 307 
results show that mutations in the macrodomain and the PLP2 domain result in elevated 308 
levels of type I IFN mRNA expression during infection of macrophages, further 309 
supporting the role of macrodomain and PLP2 in modulating host innate immunity.  310 
Because the ts mutant viruses had reduced replication efficiency and elicited 311 
type I IFN production during infection of macrophages, we were interested in evaluating 312 
the pathogenicity of these viruses. To this end, C57BL/6 mice were intracranially 313 
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inoculated with 600 plaque-forming units (PFUs) of virus and monitored for weight loss 314 
and mortality. As shown in Figure 7B, all WT virus-infected mice lost weight rapidly and 315 
succumbed to infection by day 11 post-infection. In contrast, the mutant virus-infected 316 
mice exhibited transient or no weight loss during the infection period and all mice 317 
survived. These results demonstrate that the ts mutant viruses are attenuated in vivo, 318 
and those mutations adjacent to the catalytic sites of the macro- and PLP2 domains can 319 
modulate viral pathogenesis. 320 
 321 
Discussion 322 
Identifying viral factors that modulate the immune response to viral infection 323 
provides new opportunities for developing novel antiviral interventions. Here, we 324 
described an unanticipated interplay between two previously characterized virulence 325 
factors, the macrodomain and the papain-like protease, of coronaviruses. The 326 
enzymatic activities of these domains have been implicated in removing post-327 
translational modifications: macrodomains remove mono- or poly-ADP-ribose from 328 
proteins (18, 22, 23); deubiquitinating activity of viral papain-like proteases removes 329 
mono- or poly-ubiquitin chains from signaling proteins (30, 32, 47). Our study stems 330 
from characterizing a temperature-sensitive mutant virus that harbored mutations within 331 
both the macrodomain and the PLP2 domain of nsp3. We found that the mutation within 332 
the macrodomain (G554D) was associated with the most significant temperature-333 
sensitive phenotype, but that this alteration of the macrodomain reverted to the wild-334 
type phenotype at high frequency. However, viruses containing mutations in both the 335 
macrodomain and PLP2 domain reverted less frequently, consistent with the PLP2 336 
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domain having an enhancing effect on the ts phenotype. Although these two enzymes 337 
reside within the same nsp3 polypeptide (Figure 1A), to our knowledge, this is the first 338 
suggestion of an interplay between these domains. By expressing the macrodomain 339 
and papain-like protease 2 domain on independent expression plasmids, we were able 340 
to evaluate and detect co-immunoprecipitation of the proteins, consistent with either a 341 
direct or indirect interaction. Furthermore, we report that the mutations identified in the 342 
macrodomain and PLP2 domain destabilize the proteins, as revealed by proteasome-343 
dependent degradation. Lastly, we demonstrate that these mutant viruses promote type 344 
I IFN production from macrophages in tissue culture and are attenuated in mice. This 345 
work confirms and extends previous studies that independently identified the 346 
macrodomain and the papain-like protease 2 domain as modulators of the innate 347 
immune response and virulence factors [reviewed in (31, 48, 49), (35)].   348 
Macrodomains have been shown to play a role in the virulence of positive-sense 349 
RNA viruses including hepatitis E virus (HEV), alphaviruses, and coronaviruses 350 
[reviewed in (48, 49)]. Studies of the alphavirus Chikungunya virus (CHIKV) revealed 351 
that the macrodomain at the N terminus of nsP3 hydrolyzes ADP-ribose groups from 352 
mono-ribosylated proteins and that this de-ribosylating activity is critical for CHIKV 353 
replication in vertebrate and insect cells, and for virulence in mice (50). Interestingly, 354 
viruses engineered to encode a mutation of the CHIKV macrodomain catalytic site 355 
rapidly reverted to the wild-type sequence (51), similar to the high frequency reversion 356 
we reported for the MHV MACmut virus (Figure 3). Studies of the role of the 357 
macrodomain during coronavirus replication indicate that catalytic activity is not required 358 
for virus replication in interferon non-responsive cell lines (19, 20, 24). However, 359 
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catalytic activity is important for replication in primary cells and in mice, implicating the 360 
macrodomain in evading the innate immune response and promoting viral pathogenesis 361 
(20, 24, 25). Identifying the ribosylated substrates that are targeted by the viral 362 
enzymatic activity is an important future direction for this work.   363 
Our study implicated an adjacent viral domain, the papain-like protein 2 domain, 364 
as an interacting partner with the macrodomain. Interestingly, the helicase domain 365 
adjacent to the macrodomain of hepatitis E virus (HEV) was found to modulate 366 
macrodomain activity. Biochemical assays revealed that the presence of the HEV 367 
helicase domain in cis enhanced the binding of the macrodomain to ADP-ribose and 368 
stimulated the hydrolase activity (22).  Furthermore, we previously found that the 369 
mutations in the Ubl-2 domain could cause a ts phenotype and destabilize the PLP2 370 
domain (52). Here, we found that the mutations in the macro- and PLP2 domains 371 
destabilized the replicase proteins, as shown by the more rapid degradation of the 372 
proteins after temperature shift.  We speculate that there may be a dynamic interaction 373 
between adjacent domains within the nsp3 polyproteins.  374 
As a multidomain protein, nsp3 must hold a sophisticated architecture to function 375 
properly and precisely. To date, four essential functions have been documented for this 376 
multidomain protein: 1) interaction of the Ubl-1 domain with the nucleocapsid (N) protein 377 
is important for genomic RNA synthesis and encapsidation (39, 40); 2) proteolytic 378 
processing of the N-terminal region of pp1a and pp1ab to release nsp1, nsp2, and nsp3 379 
(26, 27); 3) hijacking the cellular reticular network in concert with other membrane-380 
associated proteins (nsp4 and nsp6) to form virus-specific membrane structures for 381 
RNA synthesis (11, 12); and 4) antagonizing the innate immune response through the 382 
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actions of the de-ADP-ribosylating activity of the macrodomain and the deubiquitinating 383 
activity of the PLP2 domain [reviewed in (31, 48)]. The removal of post-translational 384 
modifications such as ADP-ribosylation and poly-ubiquitination could be directed either 385 
at cellular proteins to redirect them for use during viral replication, or to subvert 386 
signaling of innate immune responses. Ultimately, structural and biochemical studies 387 
will be needed to fully investigate the multiple cis and trans interactions of nsp3 and to 388 
determine if there is a dynamic interplay that modulates the stability, substrate 389 
specificity and/or affinity of the enzymes and substrates. 390 
We found that the MAC/PLP2mut virus recapitulated the ts phenotype of tsNC11 391 
(Figure 1B).  However, it is possible that some or all of the other mutations we identified 392 
by deep sequencing (I4V and T543I in nsp2 and P23S in nsp10) may contribute in a 393 
subtle way to the phenotype of tsNC11. Nsp2 was shown to be dispensable for MHV 394 
and SARS-CoV replication, but the deletion of the nsp2 coding sequence resulted in 395 
decreased viral replication and RNA synthesis (53). For nsp10, previous studies 396 
revealed that this protein plays critical roles in the 3C-like protease-mediated 397 
polyprotein processing and viral RNA synthesis (54, 55). The results from these studies 398 
indicate that the mutations in nsp2 and nsp10 may also contribute to a ts phenotype. 399 
While our study focuses on the contribution of the macrodomain and PLP2, further 400 
studies are needed to fully evaluate the impact of other ORF1a mutations on the 401 
replication and pathogenesis of coronaviruses.  402 
In summary, we report what is, to our knowledge, the first indication of an 403 
interplay between the macrodomain and papain-like protease 2 domain of CoV nsp3. 404 
We found that this interplay impacts virus replication efficiency, innate immune 405 
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antagonism and virulence in mice. A detailed understanding of the relationship between 406 
the macro- and PLP2 domains will require further structural and enzymatic studies. We 407 
anticipate that the genetic analysis, co-immunoprecipitation and in vivo pathogenesis 408 
outcomes reported here will facilitate these future studies.  409 
 410 
Materials and Methods 411 
Virus and cells. Human embryonic kidney (HEK) 293T cells (CRL-11268, ATCC) were 412 
cultured in Dulbecco’s modified Eagle medium (DMEM) with 10% fetal bovine serum 413 
(FBS) and 2% L-glutamine. Delayed brain tumor (DBT) cells were grown in minimal 414 
essential media (MEM) (catalog no. 21800-0400; Gibco) supplemented with 10% 415 
tryptose phosphate broth (TPB) media, 5% heat-inactivated FBS (Atlanta Biological), 416 
2% penicillin/streptomycin (pen/strep; HyClone), and 2% L-glutamine. The BHK-MHVR 417 
cell line was kindly provided by Mark Denison at Vanderbilt University Medical Center 418 
and cultured in Dulbecco’s modified Eagle medium (DMEM) (catalog no. 12100-046, 419 
Gibco) supplemented with 10% heat-inactivated FBS and G418 (0.8 mg/mL; HyClone). 420 
Differentiated BMDMs were maintained in bone marrow macrophage media containing 421 
DMEM (catalog no. 10-017-CV, Corning) supplemented with 30% L929 cell 422 
supernatant, 20% FBS, 1% L-glutamine, 1% sodium pyruvate, and 1% pen/strep. HeLa-423 
MHVR cells (56) were grown in DMEM (catalog no. 12100-046, Gibco) supplemented 424 
with 10% FBS, 1% L-glutamine, 0.5% HEPES, and 1% pen/strep.  Temperature-425 
sensitive MHV strain tsNC11 was propagated in DBT cells at 32˚C. The infectious clone 426 
MHV-A59 strain (GenBank accession no. AY910861) serves as wild-type (icWT) virus 427 
for this study. 428 
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Deep sequencing and bioinformatic analysis. Viral RNA was extracted from the 429 
supernatant of tsNC11-infected DBT cells incubated at 32˚C. Isolated RNA was sent to 430 
GENEWIZ, Inc. for cDNA library preparation and Illumina Miseq high-throughput 431 
sequencing. Raw reads were subject to pairing and trimming and aligned to the genome 432 
sequence of the synthetic construct of MHV A59 strain (GenBank accession no. 433 
AY910861) using Geneious software (Geneious R7, https://www.geneious.com). A 434 
medium-low sensitivity and an iteration of up to 5 times were chosen. A total of 195,824 435 
sequences with a mean coverage of 898.8 were aligned to the MHV Synthetic Construct 436 
template. Polymorphisms were detected using the “find variations/SNPs” tool. 437 
Parameters included a minimum coverage of 5 with a minimum variant frequency of 438 
25% in order for a variation to be called. The maximum variant p-value was set at 10-6 439 
and the minimum strand bias p-value was set at 10-5 when exceeding 65% bias. We 440 
focused our analysis on the first 12 kb of the replicase gene, since previous studies 441 
reported the ts phenotype was associated with changes in this region (36, 57).  442 
Generation of mutant viruses. All infectious clones were generated using the reverse 443 
genetics system previously established for MHV-A59 (37). Mutations identified by deep 444 
sequencing within the macrodomain and PLP2 domain were introduced into plasmids A 445 
and B, respectively, then verified by sequencing of the plasmid DNA. DNA fragments 446 
were ligated together and used for in vitro transcription of viral RNA. In vitro transcribed 447 
genomic RNA and N gene RNA was electroporated into BHK-MHVR cells, which were 448 
overlaid onto DBT cells in a T75 flask. These cells were incubated at the permissive 449 
temperature of 32oC to facilitate the replication of ts mutant viruses. Supernatants were 450 
collected at the time when cytopathic effect was evident, usually between 36 and 48 h 451 
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post-electroporation. All infectious clone mutant viruses were plaque purified, 452 
propagated on DBT cells, and subjected to full genome sequencing to validate the 453 
genotype. These infectious clones were designated MACmut, PLP2mut, and 454 
MAC/PLP2, according the locations of introduced mutations as shown in Figure 1.  455 
Temperature-sensitive assay and one-step growth kinetics. To determine the 456 
temperature sensitivity of mutant viruses, the efficiency of plating (EOP = titer 40oC/ titer 457 
32oC) of virus was measured. DBT cells were seeded into two 6-well plates at 5.0 x 105 458 
cells/well a day prior to infection. Each viral stock supernatant was serially diluted and 459 
inoculated onto the DBT cells. After 1 h incubation at 37oC, inoculum was removed, and 460 
cells were subsequently overlaid with 0.8% 2x MEM/agar mixture. One plate was 461 
incubated at 32oC for 60 h, and the second plate was incubated at 40oC for 48 h. 462 
Agarose-covered cells were fixed using 4% formaldehyde for 1 h and stained using 463 
0.1% crystal violet solution after removal of agarose. Plaques were counted and titers 464 
were calculated.  465 
To evaluate the kinetics of virus replication, a one-step growth curve was generated at 466 
each temperature. Briefly, DBT cells were infected with the designated virus at 467 
multiplicity of infection of 5 for 1 h at 37oC, then plates were incubated at the specified 468 
temperatures. The supernatants were collected at indicated time points and titrated on 469 
DBT cells incubated at 32oC for 60 h. 470 
Isolation and characterizations of ts revertants. To isolate ts revertants, plaque 471 
assays were performed at 40oC. Viruses from single plaques were isolated and 472 
propagated in DBT cells at 32oC to obtain viral stocks. To determine the ts phenotype of 473 
the isolates, the isolates were titrated at both 32oC and 40oC and the EOP values were 474 
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calculated as described above. To identify any mutations within the region of macro- 475 
and PLP2 domains of the revertants, viral genomic RNA was extracted using 476 
TriReagent (MRC, Inc.) according to the manufacturer’s instruction and subsequently 477 
subject to cDNA synthesis. A genomic region (3976-6101 nt) containing the macro- and 478 
PLP2 domain was amplified by PCR using specific primers (Sense: 5’- CAA GAA AGG 479 
TCT TTA GGG CTG CTT -3’; anti-sense: 5’- GAC ACC ATC AAC CTT CTC AAA TG -480 
3’). The PCR products were sequenced and the sequencing results were compared to 481 
the tsNC11 sequence.  482 
MAC and PLP2 expression plasmids. Nucleotide sequences encoding the 483 
macrodomain [467-622 amino acids (aa) of nsp3] were amplified from a codon-484 
optimized MHV nsp3 gene (sequence available upon request) and cloned into pCAGGS 485 
vector with an HA epitope tag, designated as HA-MAC. The pCAGGS-PLP2 plasmid 486 
(PLP2-V5) was generated in a previous study (52). The coding sequence of the 487 
macrodomain through PLP2 domain (467-1085 aa) was inserted into pcDNA3.1 and 488 
fused with a c-terminal V5 epitope tag (pMP-WT). Mutations were introduced into these 489 
constructs using site-directed mutagenesis PCR or Gibson Assembly technique to 490 
generate pMP-GD (G554D), pMP-2DN (D1026N/D1071N) and pMP-GD/2DN 491 
(G554D/D1026N/D1071N), which all contain a c-terminal V5 tag. 492 
Co-immunoprecipitation. HA-MAC and PLP2-V5 plasmids were co-transfected into 493 
HEK-293T cells in 35 mm dishes. Cells were harvested using 500 L lysis buffer (20 494 
mM Tris pH 7.5, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1% Triton X-100, 2.5 mM 495 
sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM sodium ortho-vanadate, 1 496 
μg/mL leupeptin, 1 mM PSMF) and 200 g of whole cell lysates were used for 497 
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immunoprecipitation with 1 g primary mouse anti-V5 (R96025, Invitrogen) or -HA 498 
(MMS-101R-200, Biolegend) monoclonal antibody (Ab). Protein-Ab mixtures were 499 
rotated at 4oC overnight and then added 15 L magnetic protein G beads 500 
(LSKMAGA02, Millipore) for 1 h incubation. Beads were washed three times with 501 
washing buffer (lysis buffer composition except 450 mM NaCl) and eluted with 40 L 2x 502 
sample buffer (10% glycerol, 5% β-ME, 3% SDS, 7.5 mg/mL Trizma-base, bromophenol 503 
blue). Eluted products and 5% of cell lysates as input were subject to SDS-PAGE gel 504 
electrophoresis and immune-blotting with anti-V5 or anti-HA antibodies.  505 
Evaluating protein stability after addition of cycloheximide. To determine the 506 
steady-state level of protein, 0.5 g of the specified plasmid DNA was transfected into 507 
HEK-293T cells with transfection reagent TransIT-LT1 (MIR2300, Mirus) according to 508 
the manufacture’s recommendation. At 16 h post-transfection, cells were treated with 20 509 
μg/mL of cycloheximide (CHX) (5087390001, Sigma Aldrich) or a combination of 20 510 
μg/mL CHX and 10 μM MG132 (474790, Calbiochem), a proteasome inhibitor, and 511 
harvested at the indicated time points. Equal amounts of cell lysate were subjected to 512 
immunoblotting with anti-V5 or anti-β-actin (A00702, Genscript) antibodies. The relative 513 
intensity of MAC/PLP2 bands (relative to β-actin) were measured and calculated with 514 
AlphaView software (Protein Simple). To assess the rate of decay of the protein amount 515 
over time for the four viral protein types, we fit the two-parameter simple exponential 516 
nonlinear regression function, 𝑦 = 𝜃1𝑒
−𝜃2𝑥 , using the NLIN procedure in SAS 9.4 517 
software package and verified using Minitab software version 18.  In this regression 518 
equation, 𝜃1 is the initial viral amount parameter at time zero and 𝜃2 is the slope or rate 519 
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of decay parameter.  The slope parameters (𝜃2) were each compared with the WT slope 520 
using NLIN’s provided two-sided t-tests and p-values < 0.05 were deemed significant. 521 
To evaluate the steady level of replicase proteins nsp2-3 and nsp3, we 522 
performed a temperature shift experiment.  Briefly, HeLa-MHVR cells were infected with 523 
either WT or MAC/PLP2mut virus (moi = 5) and incubated at the permissive 524 
temperature for 9.5 h, when the cells were shifted to 40oC and treated with 20 ug/mL of 525 
CHX.  Whole cell lysates were prepared at 30 min intervals by the addition of lysis 526 
buffer A (4% SDS, 3% DTT, 40 % glycerol and 0.065 M Tris, pH 6.8). The lysates were 527 
passed through a 25-gage needle to break up aggregates, incubated at 37oC for 30 min 528 
and loaded onto a 6% SDS-PAGE, followed by transfer to a nylon membrane.  The 529 
membrane was incubated with a 1:2,000 dilution of rabbit polyclonal anti-nsp2-3 530 
antibody (anti-D3) (58), followed by horseradish peroxidase (HRP)-conjugated donkey 531 
anti-rabbit IgG (H+L) (Southernbiotech), and developed with Western Lightening Plus-532 
ECL reagents (PerkinElmer). The membrane was stripped and re-probed using a 533 
1:2,000 dilution of mouse anti-calnexin antibody, followed by HRP-conjugated goat anti-534 
mouse IgG (H+L), and developed as above. 535 
Reverse transcription quantitative PCR (RT-qPCR). The protocol of RT-qPCR was 536 
described previously (9) with slight modification. Briefly, BMDMs were mock-infected or 537 
infected with wild-type or mutant MHVs at a multiplicity of infection (MOI) of 1 and 538 
incubated at a permissive temperature of 32 oC. At indicated time points, cells were 539 
harvested for RNA extraction using an RNeasy Mini Kit (74104, Qiagen). An equal 540 
amount of RNA was used for cDNA synthesis using Rt2 HT First Strand Kit (330401, 541 
Qiagen). To determine IFN-11, β-actin, or MHV-A59 N gene mRNA production, qPCR 542 
 on M









was performed with specific primers for mouse IFN-11 (PPM03050B-200, Qiagen), 543 
mouse β-actin (PPM02945B-200, Qiagen) or MHV-A59 N gene (Sense: 5’- AGC AGA 544 
CTG CAA CTA CTC AAC CCA ACT C -3’; anti-sense: 5’- GCA ATA GGC ACT CCT 545 
TGT CCT TCT GCA -3’) using RT2 SYBR Green qPCR Mastermix (330502, Qiagen) in 546 
the Bio-Rad CFX96 system. The thermocycler was set as follows: one step at 95 °C (10 547 
min), 40 cycles of 95 °C (15 s), 60 °C (1 min) and plate read, one step at 95 °C (10 s), 548 
and a melt curve from 65 °C to 95 °C at increments of 0.5 °C/0.05 s. Samples were 549 
evaluated in triplicate and data are representative of three independent experiments. 550 
The levels of mRNA were relative to β-actin mRNA and expressed as 2−ΔCT [ΔCT = 551 
CT(gene of interest) − CT(β-actin)]. 552 
Evaluating viral pathogenesis. The protocol for evaluating pathogenesis of MHV was 553 
approved by the Loyola University Chicago IACUC and previously described (59). 554 
Briefly, six-week-old C57BL/6 female mice were purchased from the Jackson 555 
Laboratory. Mice were intracranially inoculated with 600 PFU in 20 μL PBS and 556 
monitored daily for changes in body weight. Infected mice were euthanized when weight 557 
loss was over 25% according to the protocol. Statistical analysis of survival rate was 558 
evaluated using the log-rank test.  559 
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 773 
Figure legends 774 
Figure 1. Evaluating the replication kinetics of coronavirus temperature-sensitive 775 
mutants at permissive and non-permissive temperatures. (A) Schematic diagram of 776 
the MHV genome and the domains of nsp3. Abbreviations: Ubl1, ubiquitin-like domain 1; 777 
Ac, acidic region; PLP1, papain-like protease 1; MAC, Macrodomain; DPUP, domain 778 
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proceeding Ubl2 and PLP2; Ubl2, ubiquitin-like domain 2; PLP2, papain-like protease 2; 779 
NAB, nucleic acid-binding domain; G2M, coronavirus group 2 marker domain; TMDs, 780 
transmembrane domains; Y, coronavirus highly-conserved domain. Representative 781 
structures of the macrodomain with ribose (229E; PDB: 3EWR) and PLP2 (MHV; PDB: 782 
4YPT) are shown in cyan and green with catalytic pockets circled and the residues 783 
involved in catalysis shown in magenta. The mutations described in this study are 784 
shown in red. (B) Growth kinetics of MHV and mutants at three temperatures. DBT cells 785 
were inoculated with the indicated virus (MOI of 5) for 1 h at 37oC and then shifted to 786 
the indicated temperatures. Culture supernatant was collected at the indicated hours 787 
post-infection and titrated in DBT cells at 32oC. The data are representative of two 788 
independent experiments. Error bars indicate ±SD. 789 
 790 
Figure 2. Analysis of plaque size and efficiency of plating at the permissive and 791 
non-permissive temperatures. (A) Representative plaque assays at 32oC and 40oC 792 
for icWT, tsNC11 and engineered mutant viruses. The dilution of the viral stock is 793 
indicated and selected to visualize ~20-50 plaques per plate. (B) Efficiency of plating 794 
(EOP) = average titer at 40oC/ average titer at 32oC. 795 
 796 
Figure 3. Analysis of small- and large-plaque variants in the MACmut virus 797 
population.  (A) MACmut isolates with distinct plaque sizes were evaluated for a ts 798 
phenotype. Sequence analysis of individual plaque-purified revertant isolates identified 799 
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mutations in the macrodomain and the adjacent downstream region in the large-plaque 800 
variants of the MACmut (B) and tsNC11(C) viruses. 801 
 802 
Figure 4. Evaluating co-immunoprecipitation of the macrodomain and the PLP2 803 
domain. (A) Schematic diagram of the individual constructs used to evaluate potential 804 
interactions between the macrodomain and PLP2. (B) Western blotting to identify 805 
expression and co-immunoprecipitation of HA-MAC and PLP2-V5. HEK-293T cells were 806 
transfected with the indicated plasmid DNAs, lysates were prepared at 18 hours post-807 
transfection, subjected to immunoprecipitation with the indicated antibody and the 808 
products analyzed by SDS-PAGE and immunoblotting. The data represent the results of 809 
three independent experiments. Astersks indicate the cross detection of IgG chains by 810 
secondary antibody. 811 
 812 
Figure 5. Mutations in macrodomain and PLP2 enhance degradation of the 813 
polypeptide. (A) Schematic diagram of constructs used to evaluate protein stability. (B 814 
and C) Western blotting detecting wild-type or mutant forms of MAC-PLP2 polypeptide 815 
in the presence of cycloheximide (CHX) or a combination of CHX and a proteasome 816 
inhibitor MG132. HEK-293T cells were transfected with the indicated expression 817 
plasmid of wild-type (WT) or mutant forms of MAC-PLP2. At 16 h post-transfection, cells 818 
were treated with 20 μg/mL of CHX or a combination of 20 μg/mL CHX and 10 μM 819 
MG132 and harvested at the indicated time points. Equal amount of cell lysate were 820 
subjected to immunoblotting with anti-V5 or anti-β-actin antibodies. The relative intensity 821 
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of MAC/PLP2 bands (relative to β-actin) were measured and calculated with AlphaView 822 
software. The experiment was repeated two times and the representative immunoblots 823 
(B) and the curves of relative intensity (C) are shown. The slope parameters of the 824 
decay curves were evaluated using non-linear regression and two-sided t-tests 825 
compared to WT. **, P<0.005; ****, P<0.0001. 826 
 827 
Figure 6.  Mutations in the macrodomain and PLP2 alter the stability of replicase 828 
protein nsp3.  HeLa-MHVR cells were infected with either icMHV-WT or 829 
MAC/PLP2mut virus (MOI of 5) and incubated at 32oC for 9.5 h, then 20 g/mL of 830 
cycloheximide (CHX) was added and cells were shifted to the non-permissive 831 
temperature.  Lysates were prepared every 30 min, and the proteins separated by SDS-832 
PAGE, and nonstructural proteins nsp2-3 and nsp3 were visualized by immunoblotting. 833 
A) Schematic diagram of MHV replicase polyprotein indicating the processing pathway 834 
and the region identified by the anti-nsp2-3 antibody. B) Outline of the experiment. C) 835 
Western blot evaluating the level of nsp2-3 and nsp3 proteins detected after shift to the 836 
non-permissive temperature. This is representative data of two independent 837 
experiments. Arrowhead indicates detections of cellular protein in all lysates. Asterisk 838 
indicates degradation products detected by anti-nsp2-3 antibody in the MAC/PLP2mut 839 
virus-infected cells. 840 
 841 
Figure 7. Macrodomain mutant viruses induce type I interferon in primary 842 
macrophages and are attenuated in mice. (A) Mouse bone marrow-derived 843 
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macrophages were infected with the indicated virus (MOI of 1) at 32°C. Total RNA was 844 
extracted at the indicated time points and subjected to RT-qPCR. The mRNA levels of 845 
IFN- (left) and N gene (right) are presented relative to β-actin. The results are 846 
representative of three independent experiments and subjected to a two-tailed, unpaired 847 
t-test. Error bars indicate ±SD. ***, P<0.001; ****, P<0.0001. n.s.: not significant. N.D.: 848 
not detected. (B) Six-week-old mice were injected intracranially with either icWT or the 849 
indicated ts mutant virus (600 PFU per mouse) and monitored for weight loss. Viral 850 
pathogenicity was evaluated by body weight loss (left) and percent survival (right). The 851 
number (n) of infected mice is indicated in parentheses. Error bars indicate ± SEM. 852 
Differences in survival rates were calculated using a log-rank test. 853 
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